The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

Background: Cyclin-Dependent Kinases (CDKs) are established anti-cancer drug targets and a new generation of CDK inhibitors are providing clinical benefits to a sub-set of breast cancer patients. We have recently shown that human CDK18 promotes efficient cellular responses to replication stress. In...

Full description

Bibliographic Details
Main Authors: Barone, Giancarlo, Arora, Arvind, Ganesh, Anil, Abdel-Fatah, Tarek, Moseley, Paul, Ali, Reem, Chan, Stephen Y.T., Savva, Constantinos, Schiavone, Kristina, Carmell, Natasha, Myers, Katie N., Rakha, Emad A., Madhusudan, Srinivasan, Collis, Spencer J.
Format: Article
Language:English
Published: Impact Journals 2018
Online Access:http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/8/25686-1008533-5-PB.pdf

Internet

http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/
http://eprints.nottingham.ac.uk/52471/8/25686-1008533-5-PB.pdf

Similar Items